Effect of thalidomide combined with CHOP on immune function, angiogenesis and inflammatory factors in patients with diffuse large B-cell lymphoma

Effect of thalidomide combined with CHOP on immune function, angiogenesis and inflammatory factors in patients with diffuse large B-cell lymphoma

Objective: To mainly explore the effect of thalidomide combined with CHOP chemotherapy regimen on immunoglobulin, VEGF, lactate dehydrogenase, inflammatory factors and other related factors in patients with diffuse large B-cell lymphoma. Methods: A total of 83 patients with diffuse large B-cell l...

Full description

Bibliographic Details
Main Authors:	Yun Wan, Yu-gang Xing, Liang-hua Wang, An-wei Dai
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2019-09-01
Series:	Journal of Hainan Medical University
Subjects:	thalidomide diffuse large b b-cell lymphoma immune function vegf inflammatory cytokines
Online Access:	http://www.hnykdxxb.com/PDF/201918/5.pdf

Similar Items

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Results of CHOP chemotherapy for diffuse large B-cell lymphoma
by: A.E. Hallack Neto, et al.
Published: (2006-10-01)

Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India
by: Babu Suresh, et al.
Published: (2019-01-01)

FREQUENCY OF FEBRILE NEUTROPENIA IN ELDERLY PATIENTS OF DIFFUSE LARGE B CELL LYMPHOMA RECEIVING MODIFIED DOSE CHOP REGIMEN OF CHEMOTHERAPY
by: Tanvir Ahmed, et al.
Published: (2019-09-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
by: Jiaxun Guo, et al.
Published: (2021-03-01)

Biweekly CHOP therapy improves therapeutic effect in the non-GCB subtype of diffuse large B-cell lymphoma
by: Zhang Qingyuan, et al.
Published: (2007-12-01)

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
by: Kim Yu, et al.
Published: (2012-08-01)

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
by: Kyoung Min Cho, et al.
Published: (2019-07-01)

Diffuse Large B Cell Lymphoma of the Breast
by: Feryal Karaca, et al.
Published: (2015-03-01)

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
by: Song G, et al.
Published: (2016-06-01)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
by: Yu Zhang, et al.
Published: (2021-03-01)

Diffuse Large B-cell Lymphoma of Testis: a Case Report and Current Literature Review
by: Yavuz Guler, et al.
Published: (2020-03-01)

Neutropenia After R-CHOP Chemotherapy in Diffuse Large B-cell Lymphoma Patients
by: Griskalia Christine, et al.
Published: (2019-09-01)

Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
by: Liu Y, et al.
Published: (2020-06-01)

Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma
by: Mubarak M. Al-Mansour, et al.
Published: (2018-06-01)

miRNA signature associated with R–CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma
by: Oscar Raul Fajardo-Ramirez, et al.
Published: (2020-12-01)

Primary diffuse large B‐cell lymphoma of the bone mimicking osteomyelitis
by: Abbas Mofidi, et al.
Published: (2021-09-01)

Primary cutaneous diffuse large B-cell lymphoma of the upper limb
by: Srinivasan R, et al.
Published: (2006-01-01)

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
by: Laurie H. Sehn, et al.
Published: (2020-06-01)

Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report
by: Asil Esper, et al.
Published: (2021-04-01)

High <it>MET</it> gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
by: Huang Wan-Ting, et al.
Published: (2013-02-01)

CHOP VS. BOCAD in elderly patients with diffuse large cell lymphoma (DLCL): Preliminary results
by: Tomašević Zoran, et al.
Published: (2002-01-01)

Primary diffuse large B-cell lymphoma of the ascending colon
by: Alan D. Gilman, et al.
Published: (2013-04-01)

Primary spinal epidural diffuse large B-cell lymphoma with paraplegia as the first manifestation: a case report
by: Shu Y, et al.
Published: (2019-08-01)

Primary hepatic diffuse large B-cell lymphoma with favorable response to immunochemotherapy
by: Nai-Wen Kang, et al.
Published: (2017-12-01)

Diffuse large B-Cell lymphoma-review
by: Rajeshwar Singh, et al.
Published: (2018-01-01)

Diffuse large B-cell lymphoma: An institutional analysis
by: Ajay Gogia, et al.
Published: (2018-01-01)

An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy
by: Jinglei Hu, et al.
Published: (2020-03-01)

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: Report of a case in the oral cavity
by: Jumana M Jaradat, et al.
Published: (2013-01-01)

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
by: Frédérique Larousserie, et al.
Published: (2019-06-01)

Primary breast diffuse large B-cell lymphoma in the era of rituximab
by: Zhang N, et al.
Published: (2016-10-01)

Adult Ileocolic Intussusception Caused by Diffuse Large B Cell Lymphoma
by: Joon Woo Park, et al.
Published: (2020-01-01)

Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma
by: Carolina Trindade Mello Medici, et al.
Published: (2020-06-01)

Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature
by: Kadabur Nagendrapp Lokesh, et al.
Published: (2014-01-01)

Diffuse large cell lymphoma and colon adenocarcinoma in patient with Waldenström’s macroglobulinaemia
by: Radojković Milica, et al.
Published: (2011-01-01)

Diffuse large B‐cell lymphoma presenting with cavitary lung disease
by: Yukiko Hibino, et al.
Published: (2020-07-01)

Intraosseous diffuse large B-cell lymphoma presenting as fracture of humerus
by: Tuphan Kanti Dolai, et al.
Published: (2014-01-01)

Immunohistochemical subtypes of non-hodgkin lymphomas with special emphasis on diffuse large B-cell lymphoma: An epidemiological study in a tertiary care center of Eastern India
by: Gaurav Pal, et al.
Published: (2021-01-01)